Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Lung Cancer

  Free Subscription


1 Am J Ind Med
1 Ann Thorac Surg
2 BMC Cancer
1 Br J Cancer
1 Cancer
1 Cancer Cell
1 Cancer Lett
2 Chest
1 Clin Cancer Res
1 Clin Lung Cancer
2 Clin Nucl Med
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Cancer Res Clin Oncol
1 J Clin Oncol
1 J Natl Cancer Inst
2 J Surg Oncol
1 J Thorac Cardiovasc Surg
1 J Thorac Oncol
1 Lancet Oncol
1 Lung Cancer
1 Oncol Rep
3 Oncologist

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Ind Med

  1. TOREN K, Neitzel RL, Eriksson HP, Andersson E, et al
    Cancer incidence among workers in soft paper mills: A cohort study.
    Am J Ind Med. 2023;66:728-735.
    PubMed         Abstract available

    Ann Thorac Surg

  2. ROSENSTEIN AL, Potter AL, Senthil P, Raman V, et al
    The Role of Salvage Surgery After Definitive Radiation for Non-small-cell Lung Cancer.
    Ann Thorac Surg. 2023 Aug 4:S0003-4975(23)00823.
    PubMed         Abstract available

    BMC Cancer

  3. YU Y, Xiao Z, Lei C, Ma C, et al
    BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells.
    BMC Cancer. 2023;23:732.
    PubMed         Abstract available

  4. SONG C, Liu X, Lin W, Lai K, et al
    Systematic analysis of histone acetylation regulators across human cancers.
    BMC Cancer. 2023;23:733.
    PubMed         Abstract available

    Br J Cancer

  5. XU M, Tu Y, Bi W, Lundberg MZ, et al
    SETDB1 tumour suppressor roles in near-haploid mesothelioma involve TP53.
    Br J Cancer. 2023;129:531-540.
    PubMed         Abstract available


  6. AGARWAL M, Liu A, Almquist D, Langlais BT, et al
    Chemoimmunotherapy in patients with extensive-stage small cell lung cancer and a poor performance status.
    Cancer. 2023 Aug 7. doi: 10.1002/cncr.34966.
    PubMed         Abstract available

    Cancer Cell

  7. DE MIGUEL FJ, Gentile C, Feng WW, Silva SJ, et al
    Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer.
    Cancer Cell. 2023 Aug 2:S1535-6108(23)00245-3. doi: 10.1016/j.ccell.2023.
    PubMed         Abstract available

    Cancer Lett

  8. WANG Y, Zhang L, Tan J, Zhang Z, et al
    Longitudinal detection of subcategorized CD44v6(+) CTCs and circulating tumor endothelial cells (CTECs) enables novel clinical stratification and improves prognostic prediction of small cell lung cancer: A prospective, multi-center study.
    Cancer Lett. 2023 Aug 6:216337. doi: 10.1016/j.canlet.2023.216337.
    PubMed         Abstract available


  9. KUMAR A, Xu B, Srinivasan D, Potter AL, et al
    Long-term Survival of American Joint Committee on Cancer 8th Edition Staging Descriptors for Clinical M1a Non-Small-Cell Lung Cancer.
    Chest. 2023 Aug 4:S0012-3692(23)05258-3. doi: 10.1016/j.chest.2023.07.4220.
    PubMed         Abstract available

    Measuring Harms of Lung Cancer Screening: An Opportunity to Improve Outcomes.
    Chest. 2023;164:294-295.

    Clin Cancer Res

  11. VALENCIA K, Montuenga LM, Calvo A
    Estrogen receptor and immune checkpoint inhibitors: new partners in lung cancer?
    Clin Cancer Res. 2023 Aug 7:CCR-23-1736. doi: 10.1158/1078-0432.CCR-23-1736.
    PubMed         Abstract available

    Clin Lung Cancer

  12. ADACHI H, Ito H, Isaka T, Murakami K, et al
    Effect of Surgical Treatment for N2-Positive c-stage III Non-Small Cell Lung Carcinoma in the "PACIFIC" Era.
    Clin Lung Cancer. 2023 Jul 25:S1525-7304(23)00144.
    PubMed         Abstract available

    Clin Nucl Med

  13. SU H, Yang L, Shen G, Tian R, et al
    Bilateral Pulmonary Enteric Adenocarcinoma on FDG PET/CT.
    Clin Nucl Med. 2023 Jun 23. doi: 10.1097/RLU.0000000000004749.
    PubMed         Abstract available

  14. HOU W, Dai J, Tian R
    Metastatic Pulmonary Desmoplastic Small Round Cell Tumor on FDG PET/CT.
    Clin Nucl Med. 2023 Jul 24. doi: 10.1097/RLU.0000000000004772.
    PubMed         Abstract available

    Int J Cancer

  15. TREITSCHKE S, Weidele K, Varadarajan AR, Feliciello G, et al
    Ex vivo expansion of lung cancer-derived disseminated cancer cells from lymph nodes identifies cells associated with metastatic progression.
    Int J Cancer. 2023 Aug 9. doi: 10.1002/ijc.34658.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  16. HE Y, Cazoulat G, Wu C, Svensson S, et al
    Quantifying the Effect of 4-Dimensional Computed Tomography-Based Deformable Dose Accumulation on Representing Radiation Damage for Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Standard-Fractionated Intensity-Modulated Radiat
    Int J Radiat Oncol Biol Phys. 2023 Aug 7:S0360-3016(23)07648.
    PubMed         Abstract available

    J Cancer Res Clin Oncol

  17. YANG T, Qiao S, Zhu X
    High-dose radiation-resistant lung cancer cells stored many functional lipid drops through JAK2/p-STAT3/FASN pathway.
    J Cancer Res Clin Oncol. 2023 Aug 9. doi: 10.1007/s00432-023-05106.
    PubMed         Abstract available

    J Clin Oncol

  18. WU JT, Wakelee HA, Han SS
    Optimizing Lung Cancer Screening With Risk Prediction: Current Challenges and the Emerging Role of Biomarkers.
    J Clin Oncol. 2023 Aug 4:JCO2301060. doi: 10.1200/JCO.23.01060.
    PubMed         Abstract available

    J Natl Cancer Inst

  19. RAPHAEL J, Richard L, Lam M, Blanchette P, et al
    Early mortality in patients with cancer treated with immune checkpoint inhibitors in routine practice.
    J Natl Cancer Inst. 2023;115:949-961.
    PubMed         Abstract available

    J Surg Oncol

  20. DEBAN M, Taqi K, Knapp GC, Soucisse M, et al
    Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma: Canadian practices and outcomes.
    J Surg Oncol. 2023;128:595-603.
    PubMed         Abstract available

  21. NIE K, Tao G, Zhu L, Zhang Y, et al
    Clinicopathological features and survival of rare primary pulmonary lymphoepithelial carcinoma: A cohort from a single center.
    J Surg Oncol. 2023;128:675-681.
    PubMed         Abstract available

    J Thorac Cardiovasc Surg

  22. D'ANDRILLI A, Maurizi G, Ciccone AM, Ibrahim M, et al
    J Thorac Cardiovasc Surg. 2023 Aug 2:S0022-5223(23)00646.
    PubMed         Abstract available

    J Thorac Oncol

  23. BEARZ A, Martini JF, Jassem J, Kim SW, et al
    Efficacy of lorlatinib in treatment-naive patients with ALK-positive advanced non-small cell lung cancer in relation to EML4::ALK variant type and ALK with or without TP53 mutations.
    J Thorac Oncol. 2023 Aug 2:S1556-0864(23)00691.
    PubMed         Abstract available

    Lancet Oncol

  24. GOURD E
    Middle-age lung screening for everyone who has smoked.
    Lancet Oncol. 2023;24:838.

    Lung Cancer

  25. CONROY MR, Dennehy C, Forde PM
    Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer.
    Lung Cancer. 2023 Jul 28:107314. doi: 10.1016/j.lungcan.2023.107314.
    PubMed         Abstract available

    Oncol Rep

  26. LIU X, Wu X, Ma Y, Zhang W, et al
    [Corrigendum] Endophytic fungi from mangrove inhibit lung cancer cell growth and angiogenesis in vitro.
    Oncol Rep. 2023;50:171.
    PubMed         Abstract available


  27. GENTZLER RD, Villaruz LC, Rhee JC, Horton B, et al
    Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399.
    Oncologist. 2023 Aug 9:oyad221. doi: 10.1093.
    PubMed         Abstract available

  28. HUNT AL, Nutcharoen A, Randall J, Papazian A, et al
    Integration of Multi-omic Data in a Molecular Tumor Board Reveals EGFR-Associated ALK-Inhibitor Resistance in a Patient With Inflammatory Myofibroblastic Cancer.
    Oncologist. 2023;28:730-736.
    PubMed         Abstract available

  29. FARHA N, Faisal MS, Allende DS, Sleiman J, et al
    Characteristics of Immune Checkpoint Inhibitor-Associated Gastritis: Report from a Major Tertiary Care Center.
    Oncologist. 2023;28:706-713.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.